From the Department of Neurosciences, Division of Neuroscience Research, Medical University of South Carolina, Charleston, South Carolina 29425 and.
J Biol Chem. 2013 Oct 4;288(40):28599-610. doi: 10.1074/jbc.M113.472878. Epub 2013 Aug 26.
Neurokinin-1 receptor (NK1R) mediates down-regulation of human norepinephrine (NE) transporter (hNET) via protein kinase C (PKC). However, native NET regulation by NK1R and the mechanism by which NK1R targets NET among other potential effectors are unknown. Effect of NK1R activation on native NET regulation and NET/NK1R interaction were studied using rat brain synaptosomes expressing native NET and NK1R as well as human placental trophoblast (HTR) cells coexpressing WT-hNET or NK1R/PKC-resistant hNET-T258A,S259A double mutant (NET-DM) and hNK1R. The selective NK1R agonist, GR73632, and Substance-P (SP) inhibited NE transport and reduced plasma membrane expression of NET and NK1R. Pretreatment with the NK1R antagonist, EMEND (aprepitant) prevented these NK1R-mediated effects. Immunoprecipitation experiments showed that NET forms stable complexes with NK1R. In HTR cells, combined biotinylation and immunoprecipitation studies revealed plasma membrane localization of NET·NK1R complexes. Receptor activation resulted in the internalization of NET·NK1R complexes. Lipid raft and immunoprecipitation analyses revealed the presence of NET·NK1R complexes exclusively in non-raft membrane fractions under basal/unstimulated conditions. However, NK1R activation led to translocation of NET·NK1R complexes to raft-rich membrane fractions. Importantly, PKCα was found in association with raft-localized NET following SP treatment. Similar to WT-NET, PKC-resistant NET-DM was found in association with NK1R exclusively in non-raft fractions. However, SP treatment failed to translocate NET-DM·NK1R complexes from non-raft fractions to raft fractions. Collectively, these results suggest that NK1R forms physical complexes with NET and that the receptor-mediated Thr(258) + Ser(259) motif-dependent translocation of NET·NK1R complexes into raft-rich microdomains facilitates NET/NK1R interaction with PKCα to coordinate spatially restricted NET regulation.
神经激肽-1 受体 (NK1R) 通过蛋白激酶 C (PKC) 介导下调人去甲肾上腺素 (NE) 转运体 (hNET)。然而,NK1R 对天然 NET 的调节以及 NK1R 在其他潜在效应器中靶向 NET 的机制尚不清楚。使用表达天然 NET 和 NK1R 的大鼠脑突触体以及共表达 WT-hNET 或 NK1R/ PKC 抗性 hNET-T258A、S259A 双突变体 (NET-DM) 和 hNK1R 的人胎盘滋养层 (HTR) 细胞,研究了 NK1R 激活对天然 NET 调节和 NET/NK1R 相互作用的影响。选择性 NK1R 激动剂 GR73632 和 P 物质 (SP) 抑制 NE 转运并减少 NET 和 NK1R 的质膜表达。NK1R 拮抗剂 EMEND (阿瑞匹坦) 预处理可防止这些 NK1R 介导的作用。免疫沉淀实验表明 NET 与 NK1R 形成稳定的复合物。在 HTR 细胞中,联合生物素化和免疫沉淀研究显示 NET·NK1R 复合物位于质膜上。受体激活导致 NET·NK1R 复合物内化。脂质筏和免疫沉淀分析显示,在基础/未刺激条件下,NET·NK1R 复合物仅存在于非筏膜部分。然而,NK1R 激活导致 NET·NK1R 复合物向富含筏的膜部分转移。重要的是,在用 SP 处理后发现 PKCα 与筏定位的 NET 相关。与 WT-NET 类似,PKC 抗性 NET-DM 仅与非筏部分的 NK1R 相关。然而,SP 处理未能将 NET-DM·NK1R 复合物从非筏部分转移到筏部分。总之,这些结果表明 NK1R 与 NET 形成物理复合物,并且受体介导的 Thr(258)+Ser(259)基序依赖性 NET·NK1R 复合物易位到富含筏的微区,促进 NET/NK1R 与 PKCα 的相互作用,以协调空间受限的 NET 调节。